A rendering of AstraZeneca's manufacturing facility at the Rivanna Futures site in Virginia. The first stage of AstraZeneca's promised $50 billion investment in US facilities is underway as it breaks ...
For a 143-year old Trinidadian firm that started off trading cocoa and grew to become a more than $1 billion a year conglomerate, buying a U.S. chemical firm with a Petersburg bleach plant last year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback